enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Analysts Defend Merck Amid Investor Concerns Over Weak ... - AOL

    www.aol.com/analysts-defend-merck-amid-investor...

    On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

  3. Merck & Co. - Wikipedia

    en.wikipedia.org/wiki/Merck_&_Co.

    Merck & Co. traces its origins to its former German parent company Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a drug store in Darmstadt. [ 27 ] [ 28 ] In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine . [ 29 ]

  4. P. Roy Vagelos - Wikipedia

    en.wikipedia.org/wiki/P._Roy_Vagelos

    In the mid-1980s, Merck & Co. discovered the drug ivermectin, capable of combatting the parasite that causes river blindness.At the time, the World Health Organization and the World Bank were conducting a campaign against the vector-borne disease in West Africa, and ivermectin was the most important drug in their arsenal.

  5. Merck Group - Wikipedia

    en.wikipedia.org/wiki/Merck_Group

    The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare ...

  6. Merck nears $1.3 billion cash deal for eye-drug company ... - AOL

    www.aol.com/news/merck-nears-1-3-billion...

    Its major drug in clinical stage, Restoret, aims to treat retinal diseases characterized by leakage that can lead to impaired vision. Merck nears $1.3 billion cash deal for eye-drug company EyeBio ...

  7. Is Merck Changing Its Strategy? - AOL

    www.aol.com/news/2013-03-07-is-merck-changing...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Global Health Innovative Technology Fund - Wikipedia

    en.wikipedia.org/wiki/Global_Health_Innovative...

    The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), 16 pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Fujifilm, GlaxoSmithKline, Johnson & Johnson, Kyowa Hakko Kirin, Merck ...

  9. Hipgnosis CEO Merck Mercuriadis Lays Out His Company’s Vision ...

    www.aol.com/news/hipgnosis-ceo-merck-mercuriadis...

    For premium support please call: 800-290-4726 more ways to reach us